Current directory: /home3/bjinbymy/public_html/indianext/wp-content/mu-plugins GHDDI And Microsoft Research Are Making Great Strides In The Development Of Novel Medications To Cure Infectious Diseases Throughout The World By Utilizing AI Technology - Companies
Indianext
No Result
View All Result
Subscribe
  • News
    • Project Watch
    • Policy
  • AI Next
  • People
    • Interviews
    • Profiles
  • Companies
  • Make In India
    • Solutions
    • State News
  • About Us
    • Editors Corner
    • Mission
    • Contact Us
    • Work Culture
  • Events
  • Guest post
  • News
    • Project Watch
    • Policy
  • AI Next
  • People
    • Interviews
    • Profiles
  • Companies
  • Make In India
    • Solutions
    • State News
  • About Us
    • Editors Corner
    • Mission
    • Contact Us
    • Work Culture
  • Events
  • Guest post
No Result
View All Result
Latest News on AI, Healthcare & Energy updates in India
No Result
View All Result
Home Companies

GHDDI And Microsoft Research Are Making Great Strides In The Development Of Novel Medications To Cure Infectious Diseases Throughout The World By Utilizing AI Technology

January 18, 2024
microsoft

Recently, there has been a notable advancement in the speed of drug development for the treatment of infectious diseases worldwide thanks to the efforts of Microsoft Research and the Global Health Drug development Institute (GHDDI) (opens in new tab). The collaborative team effectively designed many small molecule inhibitors for critical target proteins of Mycobacterium tuberculosis and coronaviruses by working closely together and utilizing generative AI and foundation models. These novel inhibitors exhibit exceptional bioactivities that either match or exceed those of the most well-known lead compounds.

The team’s collaborative efforts in generative AI, molecular physicochemical modeling, and iterative feedback loops between scientists and AI technologies are all responsible for this success. The collaborative team was able to obtain these remarkable achievements in just five months, when it normally takes several years to discover and confirm such molecules in vitro. This was made possible by the acceleration of AI. This study also demonstrates the enormous potential of AI in assisting researchers in finding or producing the fundamental components required to produce efficient cures for infectious diseases, which continue to endanger the health and lives of people everywhere.

For instance, the World Health Organization (WHO), the Centers for Disease Control, and numerous other sources report that since 2019, there have been over 772 million confirmed cases of COVID-19 globally and about 7 million fatalities from the virus. Vaccines have decreased the disease’s incidence and fatality rate, but the coronavirus still poses a major threat to world health since it is always evolving and changing. According to the World Health Organization, tuberculosis remains one of the biggest infectious disease causes of death, with COVID-19 coming in second in 2022 with 10.6 million cases of TB and 1.3 million deaths worldwide (the latest data available).

establishing the framework for novel therapies for infectious diseases
With a wealth of experience in both property prediction and molecular production, Microsoft Research has built and trained sizable AI models specifically tailored for proteins and molecules. Microsoft Research created and still owns an AI model for molecule creation that is suited for particular protein targets based on those experiences. Data scientists and medicinal chemists from GHDDI virtually screened and further improved the resulting compounds. Compound synthesis and wet-lab investigations were then conducted to quantify bioactivities. The Microsoft research team used the testing data to develop the AI model and create new compounds.

The successful synthesis of new compounds for protein targets in Mycobacterium TB and coronaviruses SARS-CoV-2 is made possible by this AI-expert-experiment integrated process. The collaborative team accelerated the structure-based drug development process in less than five months by designing multiple chemical compounds that effectively block the essential target proteins of these infections.

AI-generated compounds stand out for their unique scaffold architectures, which are significant because they open the door to the possibility of these molecules being developed into a distinct class of therapeutic candidates. These new structures not only address the growing problem of antimicrobial resistance (AMR), which is a significant obstacle in treating infectious diseases as COVID-19 and tuberculosis, but also hold the promise of more potent treatments.

“We face unprecedented challenges in the current scientific research landscape, but we also have unprecedented opportunities,” GHDDI head Dr. Sheng Ding stated. Innovation is the primary driver of scientific progress and a vital component in tackling global health issues. I’m thrilled about our partnership with Microsoft Research and pleased with the advancements we’ve made together. Our combined efforts will undoubtedly improve R&D efficiency and speed up the drug discovery process.

He said, “This shows a collaboration that crosses boundaries and disciplines.” Our synergistic abilities will propel pharmaceutical research forward, opening up new frontiers for scientific investigation. We hope to use these cutting-edge technologies in previously unexplored areas of the life sciences in the future. We will be able to address global health concerns with more thorough, insightful, and useful solutions as a result.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Editors Corner

How can Artificial Intelligence tools be a blessing for recruiters?

Will Artificial Intelligence ever match human intelligence?

Artificial Intelligence: Features of peer-to-peer networking

What not to share or ask on Chatgpt?

How can Machine Learning help in detecting and eliminating poverty?

How can Artificial Intelligence help in treating Autism?

Speech Recognition and its Wonders in your corporate life

Most groundbreaking Artificial Intelligence-based gadgets to vouch for in 2023

Recommended News

AI Next

Google: AI From All Perspectives

Alphabet subsidiary Google may have been slower than OpenAI to make its AI capabilities publicly available in the past, but...

by India Next
May 31, 2024
AI Next

US And UK Doctors Think Pfizer Is Setting The Standard For AI And Machine Learning In Drug Discovery

New research from Bryter, which involved over 200 doctors from the US and the UK, including neurologists, hematologists, and oncologists,...

by India Next
May 31, 2024
Solutions

An Agreement Is Signed By MEA, MeitY, And CSC To Offer E-Migration Services Via Shared Service Centers

Three government agencies joined forces to form a synergy in order to deliver eMigrate services through Common Services Centers (CSCs)...

by India Next
May 31, 2024
AI Next

PR Handbook For AI Startups: How To Avoid Traps And Succeed In A Crowded Field

The advent of artificial intelligence has significantly changed the landscape of entrepreneurship. The figures say it all. Global AI startups...

by India Next
May 31, 2024

Related Posts

Arm
Companies

Arm And HCLTech To Work Together On Personalized Chips For AI Uses

May 30, 2024
MARS
Companies

MARS Increases Its $50 Million Investment In India’s Infrastructure Market

May 29, 2024
Oncocross
Companies

Oncocross And JW Pharmaceutical Are Extending Their Partnership To Develop Novel Drugs Using Artificial Intelligence For Anticancer And Regenerative Medicine

May 28, 2024
openai
Companies

OpenAI and News Corp. Announce Historic Multi-Year Global Collaboration

May 27, 2024
Load More
Next Post
Artificial-Intelligence

The Ministry Of Agriculture & Farmers Welfare Is Utilizing State-Of-The-Art Artificial Intelligence (AI) Technologies To Enhance Overall Productivity And Benefit Farmers

IndiaNext Logo
IndiaNext Brings you latest news on artificial intelligence, Healthcare & Energy sector from all top sources in India and across the world.

Recent Posts

Google: AI From All Perspectives

US And UK Doctors Think Pfizer Is Setting The Standard For AI And Machine Learning In Drug Discovery

An Agreement Is Signed By MEA, MeitY, And CSC To Offer E-Migration Services Via Shared Service Centers

PR Handbook For AI Startups: How To Avoid Traps And Succeed In A Crowded Field

OpenAI Creates An AI Safety Committee Following Significant Departures

Tags

  • AI
  • EV
  • Mental WellBeing
  • Clean Energy
  • TeleMedicine
  • Healthcare
  • Electric Vehicles
  • Artificial Intelligence
  • Chatbots
  • Data Science
  • Electric Vehicles
  • Energy Storage
  • Machine Learning
  • Renewable Energy
  • Green Energy
  • Solar Energy
  • Solar Power

Follow us

  • Facebook
  • Linkedin
  • Twitter
© India Next. All Rights Reserved.     |     Privacy Policy      |      Web Design & Digital Marketing by Heeren Tanna
No Result
View All Result
  • About Us
  • Activate
  • Activity
  • Advisory Council
  • Archive
  • Career Page
  • Companies
  • Contact Us
  • cryptodemo
  • Energy next
  • Energy Next Archive
  • Home
  • Interviews
  • Make in India
  • Market
  • Members
  • Mission
  • News
  • News Update
  • People
  • Policy
  • Privacy Policy
  • Register
  • Reports
  • Subscription Page
  • Technology
  • Top 10
  • Videos
  • White Papers
  • Work Culture
  • Write For Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

IndiaNext Logo

Join Our Newsletter

Get daily access to news updates

no spam, we hate it more than you!